Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination
BackgroundVaccination against COVID-19 reduces the risk of severe COVID-19 disease and death. However, few studies have examined the safety of the COVID-19 vaccine in patients with autoimmune skin disease.ObjectivesWe sought to determine the incidence of disease exacerbation in this population follo...
Main Authors: | Grant Sprow, Mohsen Afarideh, Joshua Dan, Rui Feng, Emily Keyes, Madison Grinnell, Josef Concha, Victoria P. Werth |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.899526/full |
Similar Items
-
803 Plasmacytoid Dendritic Cells are Not Major Producers of Type 1 Interferons in Cutaneous Lupus
by: Victoria P Werth, et al.
Published: (2022-12-01) -
Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis
by: Julianne Kleitsch, BA, et al.
Published: (2023-11-01) -
Comparing dermatologic patient-reported outcome measures in cutaneous lupus erythematosus
by: Victoria P Werth, et al.
Published: (2022-09-01) -
Bullous systemic lupus erythematosus in females
by: Grant Sprow, BA, et al.
Published: (2022-10-01) -
A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets
by: Mohsen Afarideh, et al.
Published: (2022-05-01)